沃尔格林现已在28个州提供虚拟体重管理服务，使用FDA批准的GLP-1药物，费用为49美元/月，药物费用为149至199美元。 Walgreens now offers virtual weight management with FDA-approved GLP-1 drugs in 28 states for $49 visits and $149–$199/month meds.

沃尔格林斯在28个州启动了虚拟体重管理服务,通过对持照供应商的视频访问,使自付费的病人能够获得林业发展局批准的GLP-1类药物,如Wegovy。 Walgreens has launched a virtual weight management service in 28 states, offering self-pay patients access to FDA-approved GLP-1 medications like Wegovy through video visits with licensed providers. 病人每次看病要支付49美元,没有订阅费,药费从口服药片每月149美元开始,注射药片每月199美元开始,通过Walgreens的Rx储蓄发现器提供折扣。 Patients pay $49 per visit with no subscription fees, and medication costs start at $149 monthly for oral tablets or $199 for injectables, with discounts available via Walgreens’ Rx Savings Finder. 该方案面向没有保险的18至64岁成年人,提供按需提供的后续护理,是Walgreens扩大的数字保健服务的一部分。 The program, aimed at adults aged 18 to 64 without insurance coverage, provides on-demand follow-up care and is part of Walgreens’ expanded digital healthcare offerings.